Avecho Biotechnology CEO Dr. Paul Gavin joins Natalie Stoberman from the Proactive newsroom to share how the company is progressing with its CBD products and more.
In January, Avecho’s vitamin K injection has been introduced in an FDA pre-IND meeting by Athenex. In addition, Avecho's oral CBD softgel capsule for insomnia has also received ethics approval for its Phase III clinical trial.
Located in Melbourne, Australia, Avecho Biotechnology develops and commercialises innovative human and animal health products using its proprietary drug delivery system called Tocopheryl Phosphate Mixture. TPM is derived from vitamin E using unique, proprietary and patented processes and is proven to enhance the solubility and oral, dermal and transdermal absorption of drugs and nutrients.
#proactiveinvestors #avechobiotechnology #ASX #AVE #cbd #cannabinoids #vitaminkinjection #alternativewellness #biotech
In January, Avecho’s vitamin K injection has been introduced in an FDA pre-IND meeting by Athenex. In addition, Avecho's oral CBD softgel capsule for insomnia has also received ethics approval for its Phase III clinical trial.
Located in Melbourne, Australia, Avecho Biotechnology develops and commercialises innovative human and animal health products using its proprietary drug delivery system called Tocopheryl Phosphate Mixture. TPM is derived from vitamin E using unique, proprietary and patented processes and is proven to enhance the solubility and oral, dermal and transdermal absorption of drugs and nutrients.
#proactiveinvestors #avechobiotechnology #ASX #AVE #cbd #cannabinoids #vitaminkinjection #alternativewellness #biotech
